highly significantp<0.001
The consistent separation of curves across both time periods and all drug types, combined with highly significant log-rank test results (p<0.001 for all comparisons except famciclovir in period 2), provide strong evidence for a protective association between AHD use and AD treatment initiation ( online supplemental figures S1 and S2 ).